Tyme Technologies, Inc. Banner Image

Tyme Technologies, Inc.

  • Ticker TYME
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Tyme Technologies, Inc. Logo Image
  • 11-50 Employees
  • Based in New York City, New York
Tyme Technologies, Inc., is an emerging biotechnology company developing cancer metabolism-based therapeutics that are intended to be broadly effective across tumor types and have low toxicity profiles. Unlike targeted therapies that attempt to regulate specific mutations within cancer, the Company’s therapeutic approach is designed to take advantage of a cancer cell’s innate metabolicMore weaknesses to compromise its defenses, leading to cell death through oxidative stress and exposure to the body’s natural immune system.
4.8 / 5.0 (144)

Tyme Technologies, Inc. reports have an aggregate usefulness score of 4.8 based on 144 reviews.

Tyme Technologies, Inc.

Most Recent Annual Report

Tyme Technologies, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Tyme Technologies, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!